Previous investigations have demonstrated that genetic knockout of Vegfb (Vegfb−/−), or pharmacological inhibition of VEGF-B, resulted in restoration of insulin sensitivity and glucose tolerance, as well as preservation of insulin production and pancreatic islet morphology in the db/db T2DM mouse model13. This evidence concerns the gene VEGFB and type 2 diabetes mellitus.